T Cell News and Research

Latest T Cell News and Research

RNA loops and knots guide genetic modifications

University of Connecticut Health Center scientist, Robert Reenan, has uncovered new rules of RNA recoding - a genetic editing method cells use to expand the number of proteins assembled from a single DNA code.

21 Mar 2005

Brain research to help in fight against heart disease

Scientists at the University of Liverpool, supported by the British Heart Foundation, are studying blood flow in the brain to further medical understanding of cardiovascular disease.

21 Mar 2005

Research to improve bone marrow transplant outcomes

The National Marrow Donor Program (NMDP) and its affiliate, the Center for International Blood and Marrow Transplant Research (CIMBTR), are supporting clinical trials to determine the best unrelated marrow and blood cell transplant procedures for patients and donors.

21 Mar 2005

Key target for Foot-and-Mouth drug revealed

A complete picture of Foot-and-Mouth Disease's key replication enzyme could lead to the development of new drugs to control the disease without recourse to vaccination or slaughter, scientists report today.

21 Mar 2005

UK grows stem cells free of animal products

Dr Paul de Souza and scientists at the Roslin Institute have successfully created human cells without using animal products.

17 Mar 2005

UK leads race to produce world’s first clinical grade stem cells

The University of Sheffield has received a £2.6m grant to create some of the world’s first embryonic stem cell lines that can be used for medicinal purposes.

16 Mar 2005

Link between C-reactive protein, heart disease and stroke

The cells that line the arteries are able to produce C-reactive protein, according to a study funded by the National Institutes of Health and published in the April issue of American Journal of Pathology.

16 Mar 2005

Study reveals how brain's immune system fights viral encephalitis

The findings, published as the cover study in the latest issue of Virology, show that proteins in neurons fight the virus at multiple stages - by preventing the formation of viral RNA and proteins, and blocking the virus' release, which could infect other cells in the brain.

16 Mar 2005

Method for mass-producing embryonic stem cells

That's important because traditional laboratory methods used to grow these cells are costly and don't produce cells fast enough to respond to increasing demands for human embryonic stem cells, said Shang-Tian Yang, a professor of chemical and biomolecular engineering at Ohio State University.

16 Mar 2005

Time for ethical reflection is before experimentation begins

The time for ethical reflection is before experimentation begins, especially in the case of potential new methods for creating human embryos for research, according to bioethicists from Wake Forest University Baptist Medical Center and the Mayo Clinic in the spring issue of Ethics & Medicine.

16 Mar 2005

Cancer survival comes at its own price

Patients who hear the dreaded words "you have cancer" invariably look forward to the day the doctor tells them "you're cured." But University of Florida researchers say survival often comes at its own price -- the mind may need mending even after the body heals.

16 Mar 2005

Q. What turns an obese person into a person with diabetes? - A. Leptin

Twin epidemics of obesity and type 2 diabetes are bearing down on the world's population, threatening the lives of hundreds of millions of people. But scientists are still trying to determine how the two conditions are linked, and what it takes to turn an obese person into a person with diabetes.

16 Mar 2005

Diabetes Busting Burgers!

Chemists with the U.S. Department of Agriculture recently presented a preliminary report to the 229th national meeting of the American Chemical Society, in which they say they have discovered a form of soluble cellulose that, if added to high-fat food. The new finding could soon benefit people who regularly eat fast-foods that are high in fat.

16 Mar 2005

More research on Vitamin E surprises scientists

50 years of research into the supposed benefits of taking vitamin E has extolled its antioxidant potential to offer a variety of potential health benefits, including reducing the risk of Alzheimer's, cancer and heart disease.

15 Mar 2005

Starpharma launches new start-up biotechnology company

Starpharma Holdings Limited today announced the establishment of a start-up biotechnology company (as a foundation shareholder).

15 Mar 2005

Drug combo gives lung cancer patients longer life

Preliminary results from a large randomized clinical trial, sponsored by the National Cancer Institute (NCI), by a network of researchers led by the Eastern Cooperative Oncology Group. Genentech, Inc., have shown that patients with previously untreated advanced non-squamous non-small cell lung cancer who received bevacizumab (Avastin) in combination with standard chemotherapy lived longer than patients who received the same chemotherapy without bevacizumab.

15 Mar 2005

Discovery of key molecule that controls the growth, spread and survival of pancreatic cancer cells

Pancreatic cancer kills 30,000 Americans every year. Not only is there no cure, but there are no effective treatments. That may change if a new finding by Mayo Clinic researchers continues to show promise.

15 Mar 2005

Fasting every other day, while cutting few calories, may reduce cancer risk

New research at the University of California, Berkeley, raises such a possibility. It shows that healthy mice given only 5 percent fewer calories than mice allowed to eat freely experienced a significant reduction in cell proliferation in several tissues, considered an indicator for cancer risk.

15 Mar 2005

Link between a critical cancer pathway and an Epstein-Barr Virus (EBV) protein

Researchers at the University of Pennsylvania School of Medicine have identified a link between a critical cancer pathway and an Epstein-Barr Virus (EBV) protein known to be expressed in a number of EBV-associated cancers.

15 Mar 2005

New immunotherapeutic approach against anthrax

The anthrax attacks in the aftermath of September 11, 2001 in the USA have illustrated the high potential of anthrax for misuse in bio-terrorism. Dissemination of anthrax by letters led to the death of 5 people and chemotherapeutic treatment of 30,000 individuals.

15 Mar 2005